StreetInsider.com News Articles

Form 10-K/A Sensei Biotherapeutics, For: Dec 31

Tue, 02 Jun 2026 09:01:00 -0400

si-local-file:///var/storage/secattach/20260602/26588709.html

Form 10-K/A Sensei Biotherapeutics, For: Dec 31

Tue, 02 Jun 2026 09:01:00 -0400

si-local-file:///var/storage/secattach/20260602/26588709.html

Sensei Biotherapeutics (SNSE) files for 24.87M share offering by selling stockholders

Tue, 02 Jun 2026 09:00:02 -0400

Sensei Biotherapeutics (NASDAQ: SNSE) has filed for up to 24,868,028 share offering by selling stockholders.

Sensei Biotherapeutics (SNSE) files for 24.87M share offering by selling stockholders

Tue, 02 Jun 2026 09:00:02 -0400

Sensei Biotherapeutics (NASDAQ: SNSE) has filed for up to 24,868,028 share offering by selling stockholders.

Form S-3/A Sensei Biotherapeutics,

Tue, 02 Jun 2026 08:56:00 -0400

si-local-file:///var/storage/secattach/20260602/26588398.html

Form S-3/A Sensei Biotherapeutics,

Tue, 02 Jun 2026 08:56:00 -0400

si-local-file:///var/storage/secattach/20260602/26588398.html

Form 4 Sensei Biotherapeutics, For: Jun 01 Filed by: Cambrian BioPharma Inc

Mon, 01 Jun 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260601/26585100.html

Form 4 Sensei Biotherapeutics, For: Jun 01 Filed by: Cambrian BioPharma Inc

Mon, 01 Jun 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260601/26585100.html

Form 4 Sensei Biotherapeutics, For: Jun 01 Filed by: Peyer James

Mon, 01 Jun 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260601/26585078.html

Form 4 Sensei Biotherapeutics, For: Jun 01 Filed by: Peyer James

Mon, 01 Jun 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260601/26585078.html

Cantor Fitzgerald Starts Sensei Biotherapeutics (SNSE) at Overweight

Fri, 29 May 2026 06:08:06 -0400

Cantor Fitzgerald analyst Li Watsek initiates coverage on Sensei Biotherapeutics (NASDAQ: SNSE) with a Overweight rating.

For an analyst ratings summary and ratings history on Sensei Biotherapeutics click here. For more ratings news on Sensei Biotherapeutics click here.

Shares of Sensei Biotherapeutics closed at $17.59 yesterday.

Lucid Capital Markets Starts Sensei Biotherapeutics (SNSE) at Buy

Thu, 28 May 2026 07:06:23 -0400

Lucid Capital Markets analyst Christopher Liu initiates coverage on Sensei Biotherapeutics (NASDAQ: SNSE) with a Buy rating and a price target of $50.00.

The analyst comments "Sensei Biotherapeutics (SNSE) is a clinical-stage biotechnology company developing PIKTOR (obtained through the recent reverse merger of Faeth Therapeutics), an investigational oral combination therapy consisting of two small molecules (serabelisib, a PI3Kα-selective inhibitor, and sapanisertib, an mTORC1/mTORC2 inhibitor), which is being evaluated in 2L advanced endometrial cancer (EC) and HR+/HER2- breast cancer (BC). PIKTOR's design rationale is to deliver more complete PI3K-pathway shutdown than single-node inhibitors (SNIs) like alpelisib, inavolisib, or capivasertib by simultaneously hitting

Lucid Capital Markets Starts Sensei Biotherapeutics (SNSE) at Buy

Thu, 28 May 2026 07:06:23 -0400

Lucid Capital Markets analyst Christopher Liu initiates coverage on Sensei Biotherapeutics (NASDAQ: SNSE) with a Buy rating and a price target of $50.00.

Form DEFA14A Sensei Biotherapeutics,

Fri, 22 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260522/26541439.html

Form DEFA14A Sensei Biotherapeutics,

Fri, 22 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260522/26541439.html

Form 8-K Sensei Biotherapeutics, For: May 22

Fri, 22 May 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260522/26541385.html

Form 8-K Sensei Biotherapeutics, For: May 22

Fri, 22 May 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260522/26541385.html

Citi Starts Sensei Biotherapeutics (SNSE) at Buy

Fri, 22 May 2026 05:01:57 -0400

Citi analyst Geo initiates coverage on Sensei Biotherapeutics (NASDAQ: SNSE) with a Buy rating and a price target of $55.00.

For an analyst ratings summary and ratings history on Sensei Biotherapeutics click here. For more ratings news on Sensei Biotherapeutics click here.

Shares of Sensei Biotherapeutics closed at $17.56 yesterday.

Citi Starts Sensei Biotherapeutics (SNSE) at Buy

Fri, 22 May 2026 05:01:57 -0400

Citi analyst Geo initiates coverage on Sensei Biotherapeutics (NASDAQ: SNSE) with a Buy rating and a price target of $55.00.

For an analyst ratings summary and ratings history on Sensei Biotherapeutics click here. For more ratings news on Sensei Biotherapeutics click here.

Shares of Sensei Biotherapeutics closed at $17.56 yesterday.

Form DEFA14A Sensei Biotherapeutics,

Thu, 21 May 2026 17:14:00 -0400

si-local-file:///var/storage/secattach/20260521/26536839.html

Form DEFA14A Sensei Biotherapeutics,

Thu, 21 May 2026 17:14:00 -0400

si-local-file:///var/storage/secattach/20260521/26536839.html

Form 8-K Sensei Biotherapeutics, For: May 21

Thu, 21 May 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260521/26536807.html

Form 8-K Sensei Biotherapeutics, For: May 21

Thu, 21 May 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260521/26536807.html

Form 4 Sensei Biotherapeutics, For: Apr 02 Filed by: MILLENNIUM GROUP MANAGEMENT LLC

Fri, 15 May 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260515/26506239.html

Form 4 Sensei Biotherapeutics, For: Apr 02 Filed by: MILLENNIUM GROUP MANAGEMENT LLC

Fri, 15 May 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260515/26506239.html